Evidence map›Paper›PMID 29933044›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2019

Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis.

Thomas J Bell, Oliver J Brand, David J Morgan, Samira Salek-Ardakani, Christopher Jagger, Toshifumi Fujimori, Lauren Cholewa, Viranga Tilakaratna, Jörgen Östling, Matt Thomas and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Oral hymecromone decreases hyaluronan in human study participants.The Journal of clinical investigation · 2022
    Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Hyaluronan Ameliorates Viral Pneumonia in Mice and Humans by Inhibiting Transcription Factor E2F1.American journal of respiratory cell and molecular biology · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Sex-based differences in persistent lung inflammation following influenza infection of juvenile outbred mice.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Thomas J BellManchester Collaborative Centre for Inflammation Research, University of Manchester, UK; Inflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, UK.
Oliver J BrandManchester Collaborative Centre for Inflammation Research, University of Manchester, UK.
David J MorganManchester Collaborative Centre for Inflammation Research, University of Manchester, UK.
Samira Salek-ArdakaniManchester Collaborative Centre for Inflammation Research, University of Manchester, UK.
Christopher JaggerManchester Collaborative Centre for Inflammation Research, University of Manchester, UK.
Toshifumi FujimoriManchester Collaborative Centre for Inflammation Research, University of Manchester, UK.
Lauren CholewaManchester Collaborative Centre for Inflammation Research, University of Manchester, UK.
Viranga TilakaratnaWellcome Trust Centre for Cell-Matrix Research, Division of Cell-Matrix Biology & Regenerative Medicine, School of Biology, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, UK.
Jörgen ÖstlingRespiratory, Inflammation & Autoimmunity IMED, AstraZeneca, Gothenburg, Sweden.
Matt ThomasRespiratory, Inflammation & Autoimmunity IMED, AstraZeneca, Gothenburg, Sweden.
Anthony J DayWellcome Trust Centre for Cell-Matrix Research, Division of Cell-Matrix Biology & Regenerative Medicine, School of Biology, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, UK.
Robert J SnelgroveInflammation, Repair and Development, National Heart and Lung Institute, Imperial College London, UK.
Tracy HussellManchester Collaborative Centre for Inflammation Research, University of Manchester, UK. Electronic address: tracy.hussell@manchester.ac.uk.
University of Manchester · GBAstraZeneca (Sweden) · SEManchester Academic Health Science Centre · GBImperial College London · GB

Funding

Wellcome Trust 202865/Z/16/Z
6 · The paper itself

Abstract

Little is known about the impact of viral infections on lung matrix despite its important contribution to mechanical stability and structural support. The composition of matrix also indirectly controls inflammation by influencing cell adhesion, migration, survival, proliferation and differentiation. Hyaluronan is a significant component of the lung extracellular matrix and production and degradation must be carefully balanced. We have discovered an imbalance in hyaluronan production following resolution of a severe lung influenza virus infection, driven by hyaluronan synthase 2 from epithelial cells, endothelial cells and fibroblasts. Furthermore hyaluronan is complexed with inter-α-inhibitor heavy chains due to elevated TNF-stimulated gene 6 expression and sequesters CD44-expressing macrophages. We show that intranasal administration of exogenous hyaluronidase is sufficient to release inter-α-inhibitor heavy chains, reduce lung hyaluronan content and restore lung function. Hyaluronidase is already used to facilitate dispersion of co-injected materials in the clinic. It is therefore feasible that fibrotic changes following severe lung infection and inflammation could be overcome by targeting abnormal matrix production.

Indexed as

Alpha-GlobulinsAnimalsCell Adhesion MoleculesEndothelial CellsEpithelial CellsFemaleFibroblastsHumansHyaluronan ReceptorsHyaluronan SynthasesHyaluronic AcidInfluenza A Virus, H1N1 SubtypeInfluenza, HumanMacrophagesMicePulmonary Disease, Chronic ObstructiveAlpha-GlobulinsCD44 protein, humanCell Adhesion MoleculesHAS2 protein, humanHyaluronan ReceptorsHyaluronan SynthasesHyaluronic Acidinter-alpha-inhibitorTNFAIP6 protein, humanFibroblastsInflammationInfluenzaLungLung functionMatrix

Identifiers

PMID29933044
PMCPMC6548309
OpenAlexW2809320542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.